The Impact of Vitamin D and Its Dietary Supplementation in Breast Cancer Prevention: An Integrative Review

Overview

Journal Nutrients

Date 2024 Mar 13

PMID 38474702

Authors

Antia Torres

Carla Cameselle

Paz Otero

Jesus Simal-Gandara

Affiliations

Soon will be listed here.

Abstract

Vitamin D deficiency is currently a significant public health issue closely linked to numerous diseases, such as breast cancer. This study aims to determine the estimated optimal serum levels of vitamin D to have a protective effect against breast cancer, in addition to exploring the biological mechanisms and risk factors involved. A literature search of articles published in the last 5 years was conducted, and simple statistical analyses using mean and standard deviation were performed to calculate the average concentration of vitamin D from different available studies. It has been observed that serum levels of vitamin D ≥ 40.26 ng/mL ± 14.19 ng/mL could exert a protective effect against breast cancer. Additionally, various biological mechanisms, such as those related to the immune system, and risk factors like diet implicated in this relationship were elucidated. Consequently, it can be concluded that proper serum levels of vitamin D may have a protective effect against breast cancer, and dietary supplementation may be an appropriate procedure to achieve these optimal vitamin D concentrations.

Citing Articles

Levels of Serum 25-Hydroxy Vitamin D in Benign and Malignant Breast Disease Patients: An Observational Study.

Soni D, Tiwari A, Kushwah P, Dubey S, Khan S Cureus. 2025; 17(1):e78283.

PMID: 40027034 PMC: 11872066. DOI: 10.7759/cureus.78283.

Cardiotoxicity in Breast Cancer: Impact of Clinical Classifications and Treatment on Heart Health.

Murg S, Matis L, Moldovan A, Schwarz-Madar A, Trifan D, Ghitea T Cancers (Basel). 2025; 16(24.

PMID: 39766180 PMC: 11674351. DOI: 10.3390/cancers16244281.

Comparative Analysis of Vitamin D, Folic Acid, and Trace Minerals Levels in Various Stages of Invasive Ductal Breast Cancer.

Helena V, Arumugam S, Muninathan N, Baskaran K, Tasneem A Cureus. 2024; 16(10):e70593.

PMID: 39483603 PMC: 11525603. DOI: 10.7759/cureus.70593.

Effects of Selective and Nonselective Beta Blockers on Bone Mineral Density in Mexican Patients with Breast Cancer.

Mejia-Barradas C, Amador-Martinez A, Lara-Padilla E, Cardenas-Rodriguez N, Ignacio-Mejia I, Martinez-Lopez V Cancers (Basel). 2024; 16(16).

PMID: 39199661 PMC: 11352457. DOI: 10.3390/cancers16162891.

The protective effect of vitamin D on ovarian reserve and anti-mullerian hormone in patients undergoing chemotherapy for breast cancer, a randomized phase ΙΙ clinical trial.

Dastmardi Z, Lashkari M, Saeedian A, Aghili M, Alipour S Cancer Rep (Hoboken). 2024; 7(6):e2104.

PMID: 38925607 PMC: 11194676. DOI: 10.1002/cnr2.2104.

References

Dankers W, Colin E, van Hamburg J, Lubberts E . Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. Front Immunol. 2017; 7:697. PMC: 5247472. DOI: 10.3389/fimmu.2016.00697. View

Kholghi Oskooei V, Geranpayeh L, Omrani M, Ghafouri-Fard S . Assessment of functional variants and expression of long noncoding RNAs in vitamin D receptor signaling in breast cancer. Cancer Manag Res. 2018; 10:3451-3462. PMC: 6140719. DOI: 10.2147/CMAR.S174244. View

Kazemi S, Esmaieli-Bandboni A, Malekshahi Z, Shahbaz Sardood M, Hashemi M, Majidzadeh K . Vitamin D receptor gene polymorphisms and risk of breast cancer in Iranian women. Ann Med Surg (Lond). 2021; 73:103150. PMC: 8666522. DOI: 10.1016/j.amsu.2021.103150. View

Blasiak J, Chojnacki J, Pawlowska E, Jablkowska A, Chojnacki C . Vitamin D May Protect against Breast Cancer through the Regulation of Long Noncoding RNAs by VDR Signaling. Int J Mol Sci. 2022; 23(6). PMC: 8950893. DOI: 10.3390/ijms23063189. View

Alimirah F, Peng X, Yuan L, Mehta R, von Knethen A, Choubey D . Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation. Exp Cell Res. 2012; 318(19):2490-7. DOI: 10.1016/j.yexcr.2012.07.020. View

Edvardsen K, Veierod M, Brustad M, Braaten T, Engelsen O, Lund E . Vitamin D-effective solar UV radiation, dietary vitamin D and breast cancer risk. Int J Cancer. 2010; 128(6):1425-33. DOI: 10.1002/ijc.25463. View

Welsh J . Vitamin D and Breast Cancer: Mechanistic Update. JBMR Plus. 2021; 5(12):e10582. PMC: 8674767. DOI: 10.1002/jbm4.10582. View

Latacz M, Snarska J, Kostyra E, Fiedorowicz E, Savelkoul H, Grzybowski R . Single Nucleotide Polymorphisms in 25-Hydroxyvitamin D3 1-Alpha-Hydroxylase ( Gene: The Risk of Malignant Tumors and Other Chronic Diseases. Nutrients. 2020; 12(3). PMC: 7146376. DOI: 10.3390/nu12030801. View

Nazario C, Rosario-Rosado R, Schelske-Santos M, Mansilla-Rivera I, Ramirez-Marrero F, Nie J . Sun Exposure Is Associated with Reduced Breast Cancer Risk among Women Living in the Caribbean: The Atabey Study in Puerto Rico. Cancer Epidemiol Biomarkers Prev. 2021; 31(2):430-435. PMC: 9190767. DOI: 10.1158/1055-9965.EPI-21-0932. View

10.

Zhang N, Li L, Long Z, Du J, Li S, Yin H . Are dietary factors involved in the association of methylation and breast cancer risk?. Br J Nutr. 2021; 127(12):1868-1877. DOI: 10.1017/S0007114521002804. View

11.

Dupont C, Armant D, Brenner C . Epigenetics: definition, mechanisms and clinical perspective. Semin Reprod Med. 2009; 27(5):351-7. PMC: 2791696. DOI: 10.1055/s-0029-1237423. View

12.

Mishra D, Wu Y, Sarkissyan M, Sarkissyan S, Chen Z, Shang X . Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women. PLoS One. 2013; 8(3):e57967. PMC: 3595235. DOI: 10.1371/journal.pone.0057967. View

13.

Navarro Valverde C, Quesada Gomez J . [Vitamin D, determinant of bone and extrabone health. Importance of vitamin D supplementation in milk and dairy products]. Nutr Hosp. 2015; 31 Suppl 2:18-25. DOI: 10.3305/nh.2015.31.sup2.8678. View

14.

Santos-Martinez N, Diaz L, Ortiz-Ortega V, Ordaz-Rosado D, Prado-Garcia H, Avila E . Calcitriol induces estrogen receptor α expression through direct transcriptional regulation and epigenetic modifications in estrogen receptor-negative breast cancer cells. Am J Cancer Res. 2022; 11(12):5951-5964. PMC: 8727803. View

15.

Kutlu R, Bicer U . Evaluation of Breast Cancer Risk Levels and Its Relation with Breast Self-Examination Practices in Women. J Breast Health. 2017; 13(1):34-39. PMC: 5351462. DOI: 10.5152/tjbh.2016.2832. View

16.

Rossi R, Pericleous M, Mandair D, Whyand T, Caplin M . The role of dietary factors in prevention and progression of breast cancer. Anticancer Res. 2014; 34(12):6861-75. View

17.

Naderi M, Kordestani H, Sahebi Z, Khedmati Zare V, Amani-Shalamzari S, Kaviani M . Serum and gene expression profile of cytokines following combination of yoga training and vitamin D supplementation in breast cancer survivors: a randomized controlled trial. BMC Womens Health. 2022; 22(1):90. PMC: 8952887. DOI: 10.1186/s12905-022-01671-8. View

18.

Abe E, Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T . Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A. 1981; 78(8):4990-4. PMC: 320317. DOI: 10.1073/pnas.78.8.4990. View

19.

Sheng L, Turner A, Barratt K, Kremer R, Morris H, Callen D . Mammary-specific ablation of Cyp24a1 inhibits development, reduces proliferation and increases sensitivity to vitamin D. J Steroid Biochem Mol Biol. 2019; 189:240-247. DOI: 10.1016/j.jsbmb.2019.01.005. View

20.

Engel P, Fagherazzi G, Mesrine S, Boutron-Ruault M, Clavel-Chapelon F . Joint effects of dietary vitamin D and sun exposure on breast cancer risk: results from the French E3N cohort. Cancer Epidemiol Biomarkers Prev. 2010; 20(1):187-98. DOI: 10.1158/1055-9965.EPI-10-1039. View